Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family (Hsp40) member C11 (DNAJC11) is a mitochondrial protein and member of the J protein (Hsp40) co-chaperone family, defined by a conserved N-terminal J domain. DNAJC11 participates in the organization of the mitochondrial inner membrane, specifically in cristae formation, via physical association with the MICOS and SAM complexes at the mitochondrial membrane. As a co-chaperone, it is presumed to regulate Hsp70-mediated ATP hydrolysis and assist with protein folding, complex assembly, and protein translocation across membranes. DNAJC11 is expressed in multiple tissues and localizes to distinct submitochondrial compartments, with its major isoform found both peripherally on the outer membrane and within internal mitochondrial structures. Mutations in DNAJC11 can disrupt mitochondrial architecture, leading to neuromuscular phenotypes and motor neuron pathology in animal models. No direct disease therapies, drugs, or established biomarker roles are currently associated with DNAJC11.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member C11 (DNAJC11).